Insulet | PODD - Выручка от реализации

Биржевая цена
192.21
Изменение за день
-1.41 -0.73%
Ежемесячно
-14.76%
Ежегодный
-25.90%
Q2 прогноз
199.25




Продажи Изменить Дата
Abbott USD 11.16B 300M 2026-03
Align Technology USD 1.05B 54.3M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Cardinal Health USD 65.63B 1.63B 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
Eli Lilly USD 19.3B 1.7B 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
ICU Medical USD 540.7M 3.7M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
J&J USD 24.1B 500M 2026-03
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Solventum Corp USD 1.99B 110M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
West Pharmaceutical Services USD 844.9M 39.9M 2026-03
Zimmer Biomet Holdings USD 2.24B 240M 2025-12